Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAGBiotechnology
+$2.32 today
- Market cap
- $1.83B
- Beta
- 0.00
Volume 0.30M
Average 0.34M
COAG Total Current Assets
All assets expected to be converted to cash or used up within one year.
Hemab Therapeutics Holdings, Inc. Common StockNASDAQ: COAG
Total Current Assets · Q2 FY2026 · quarter ended Jun 2026
Total current assets of $464M in Q2 FY2026
Q2 FY2026 total current assets was $464M.
Context
- Total current assets amounted to 99.2% of total assets at the end of Q2 FY2026.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Current Assets history
USD · from the balance sheet
- Latest · FY2025
- 192.55M USD
- Year-over-year change
- —
| Period | Period end | Total Current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 192.55M | — |
Total Current Assets vs competitors
How COAG compares with its peers on the latest reported figures
- COAG's Jun 2026 total current assets of $464M is the 4th highest of the 5 companies compared; the peer median is $575.58M.
- Total current assets amounts to 99.2% of total assets for COAG, versus a peer median of 98.9%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
IRONDisc Medicine, Inc. | Sep 2026 | $697.41M | +11.2% | +59.4% | 99.7% |
| Mar 2026 | $615.74M | +41.4% | +11.2% | 79.1% | |
DMRADamora Therapeutics, Inc. | Mar 2026 | $535.41M | +3895.9% | +59.7% | 100.0% |
COAGHemab Therapeutics Holdings, Inc. Common Stock | Jun 2026 | $464M | — | — | 99.2% |
| Mar 2026 | $53.49M | -6.8% | -30.1% | 98.2% | |
| Peer median (excluding COAG) | $575.58M | +26.3% | +35.3% | 98.9% | |
Competitors are the stored peer set for COAG. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Hemab Therapeutics Holdings, Inc. Common Stock
NASDAQ:COAG
Intrinsic Alpha fair value
Locked
Current Price
$39.15
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.